Search

everythinglearnresearchcommunity

for

Search:↓

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Cats with Feline Symmetrical Alopecia can regrow hair with proper treatment based on the specific cause, including diet, medication, or stress management.

Some young Angus cattle had skin problems due to not enough vitamin A, which got better after they were given more vitamin A.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Micropigmentation is a widely accepted tattooing technique for hiding cosmetic issues and medical uses, with permanent results and few side effects, but risks infection if not done with sterile tools.

Hormonal therapies are safe and effective for treating adult women's acne.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.